Philips and Exor extend relationship agreement and raise ownership cap to 22%

The amended agreement strengthens Exor's long-term commitment to Philips while allowing the healthcare technology investor to increase its maximum shareholding from 20% to 22%

Philips and Exor have agreed to extend their long-term relationship agreement and amend its terms to allow Exor to increase its maximum ownership stake in Philips from 20% to 22%.

The revised agreement reinforces Exor's role as a long-term strategic shareholder while providing Philips with continued shareholder stability as it executes its healthcare technology strategy.

Field	Content
Alert Type	Deal
Companies	Royal Philips; Exor N.V.
Deal Type	Amendment and extension of relationship agreement
Asset or Company	Long-term strategic shareholding in Royal Philips
Technology or Modality	Healthcare technology
Deal Value	No financial consideration was disclosed. The amended agreement increases Exor's permitted maximum ownership stake from 20% to 22%.
Geography	Global
What Happened	Philips and Exor agreed to extend their existing relationship agreement, originally signed in 2023, while increasing the maximum ownership threshold Exor may hold from 20% to 22% of Philips' outstanding ordinary share capital. The agreement maintains Exor's position as a long-term minority shareholder and continues the governance framework established between the companies. No acquisition has taken place and the revised ownership limit does not require Exor to increase its holding.
Why It Matters	The amended agreement reinforces Philips' relationship with a long-term strategic investor while giving Exor additional flexibility to increase its investment if it chooses. For Philips, the arrangement supports continuity in governance and shareholder alignment as the company continues to focus on healthcare technology and long-term value creation.
Supporting Context	Exor became Philips' largest shareholder in August 2023 after acquiring a 15% stake and entering into a relationship agreement that permitted it to increase its ownership to a maximum of 20% while granting the right to nominate one Supervisory Board member.
Strategic Rationale	The extension confirms both parties' intention to continue their long-term partnership while providing Exor with greater investment flexibility without altering Philips' governance structure or strategic direction.
Potential Impact	If Exor increases its shareholding, Philips could benefit from an even more committed long-term investor. Any effect on corporate strategy or governance would remain subject to the existing terms of the relationship agreement and applicable regulations.
Key Takeaway	The amended agreement deepens Exor's long-term commitment to Philips by increasing its permitted ownership ceiling while preserving the existing strategic shareholder relationship.
What to Watch	Whether Exor chooses to increase its holding towards the new 22% limit and whether the extended relationship results in further governance or strategic collaboration announcements.
Primary Source	https://www.massdevice.com/philips-and-exor-extend-relationship-agreement-lift-ownership-cap-to-22/
Relevant Date	13 August 2026

---

Discover how nuaxia can support your next medical education initiative:

• Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector 

• Contact us on: support@nuaxia.com